Sarepta Therapeutics
SRPT
17.51
+0.01
+0.06%
Sarepta Therapeutics
US · SRPT
#2853 by market cap
Listed 1970
17.51
+0.01
+0.06%
Live - 5344 symbols - heartbeat 317s ago
· 2026-10-08 09:59
Pre-market
17.17
-1.89%
After-hours
17.69
+1.09%
Overnight
17.62
+0.69%
- Market cap
- 1.85B
- P/E (TTM)i
- -11.15
- P/Bi
- 1.21
- EPSi
- -7.13
- Div yieldi
- 0.00%
- 52W posi
- 28%
Reader sentiment
Are you bullish or bearish on SRPT?
Anonymous reader poll. Unscientific, not investment advice.
About Sarepta Therapeutics
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
- Founded
- 1980
- CEO
- Dr. Michael Severino, M.D.
- Employees
- 835
- Headquarters
- Cambridge, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- sarepta.com
Company profile
- Exchange
- US
- Symbol
- SRPT
- Market-cap rank
- #2853
- Listing date
- 1970-01-01
- Market cap
- 1.85B
- Float cap
- 1.76B
- Shares out
- 105.63M
- Float shares
- 100.54M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 09:59:42 · For reference only, not investment advice and not tailored to your situation.